Orexo AB Articles
Sweden's Orexo in respiratory research accord with AstraZeneca
28 January 2013
Janssen drops deal with Orexo for OX-CLI/OX-ESI
1 February 2012
Orexo licenses Abstral to Invida for in Asia Pacific: GlaxoSmithKline gets rights to bilastine in Spain and Poland
17 January 2011
Showing 1-6 of 6 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
